Squarepoint’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$554K Buy
2025
Q1
$321K Buy
2024
Q4
$525K Buy
2024
Q3
$63.8K Buy
2023
Q3
Sell
2023
Q2
$39.1K Buy
2022
Q1
Sell
2021
Q4
$32K Sell
2021
Q3
$97K Buy
2020
Q3
Sell
2020
Q2
$72K Buy
2020
Q1
$52K Buy
2019
Q2
Sell
2019
Q1
$184K Sell
2018
Q4
$270K Buy
2018
Q3
$436K Buy
2018
Q2
$165K Buy
2018
Q1
$154K Buy